Project Details
| Status | Active |
|---|---|
| Effective start/end date | 28/10/25 → 27/10/30 |
Clinical Trial Phase
- Phase I
- Phase II
- External Sponsor
A multicentre, open-label, Phase I/II study investigating the safety, tolerability, and preliminary efficacy of 225Ac-SSO110 in participants with extensive stage small cell lung cancer (ES-SCLC) or Merkel cell carcinoma (MCC) receiving Standard of Care (SoC) (The SANTANA-225 Study)
- Arulananda, Surein (Primary Chief Investigator (PCI))
Project: Research